Patent · US Active

Spiroindolinone pyridine derivatives

US7928233B2 · kind B2 · utility

6Cited by

4References

4Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Li Chen · Shanghai, CN
Xingchun Han · Shanghai, CN
Song Yang · Shanghai, CN
Zhuming Zhang · Fryeburg, US

Key dates

Filing date	Jan 12, 2010
Grant date	Apr 19, 2011
Priority date	—
Expiry date	Jan 12, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There are provided compounds of the formulaor a pharmaceutically acceptable salt, ester or enantiomer thereofwherein W, X, Y, V, R1 and R2 are as described herein.The compounds have utility as antiproliferative agents, especially, as anticancer agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.